304 related articles for article (PubMed ID: 15766280)
21. Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells.
Limtrakul P; Siwanon S; Yodkeeree S; Duangrat C
Phytomedicine; 2007 Jun; 14(6):381-9. PubMed ID: 17467965
[TBL] [Abstract][Full Text] [Related]
22. P-glycoprotein and 'lipid rafts': some ambiguous mutual relationships (floating on them, building them or meeting them by chance?).
Orlowski S; Martin S; Escargueil A
Cell Mol Life Sci; 2006 May; 63(9):1038-59. PubMed ID: 16721513
[TBL] [Abstract][Full Text] [Related]
23. Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells.
Ghetie MA; Ghetie V; Vitetta ES
Clin Cancer Res; 1999 Dec; 5(12):3920-7. PubMed ID: 10632321
[TBL] [Abstract][Full Text] [Related]
24. Arsenic trioxide induces apoptosis equally in T lymphoblastoid leukemia MOLT-4 cells and P-gp-expressing daunorubicin-resistant MOLT-4 cells.
Hu XM; Hirano T; Oka K
Cancer Chemother Pharmacol; 2003 Feb; 51(2):119-26. PubMed ID: 12647012
[TBL] [Abstract][Full Text] [Related]
25. Mode of action of torilin in multidrug-resistant cancer cell lines.
Kim SE; Hong YS; Kim YC; Lee JJ
Planta Med; 1998 May; 64(4):335-8. PubMed ID: 9619116
[TBL] [Abstract][Full Text] [Related]
26. Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition.
Yun UJ; Lee JH; Koo KH; Ye SK; Kim SY; Lee CH; Kim YN
Biochem Pharmacol; 2013 May; 85(10):1441-53. PubMed ID: 23473805
[TBL] [Abstract][Full Text] [Related]
27. Modulation of P-glycoprotein-mediated resistance by kaempferol derivatives isolated from Zingiber zerumbet.
Chung SY; Jang DS; Han AR; Jang JO; Kwon Y; Seo EK; Lee HJ
Phytother Res; 2007 Jun; 21(6):565-9. PubMed ID: 17335117
[TBL] [Abstract][Full Text] [Related]
28. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance.
Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D
J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059
[TBL] [Abstract][Full Text] [Related]
29. Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells.
Weerasinghe P; Hallock S; Tang SC; Trump B; Liepins A
Exp Toxicol Pathol; 2006 Aug; 58(1):21-30. PubMed ID: 16735106
[TBL] [Abstract][Full Text] [Related]
30. N-ethylmaleimide increases P-glycoprotein photoaffinity labeling with iodoaryl-azidoprazosin in multidrug resistant cells.
Wang Y; Georges E
Anticancer Res; 1997; 17(1A):357-64. PubMed ID: 9066677
[TBL] [Abstract][Full Text] [Related]
31. The elimination of P-glycoprotein over-expressing cancer cells by antimicrobial cationic peptide NK-2: the unique way of multi-drug resistance modulation.
Banković J; Andrä J; Todorović N; Podolski-Renić A; Milošević Z; Miljković D; Krause J; Ruždijić S; Tanić N; Pešić M
Exp Cell Res; 2013 Apr; 319(7):1013-27. PubMed ID: 23298945
[TBL] [Abstract][Full Text] [Related]
32. Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cells.
Troost J; Lindenmaier H; Haefeli WE; Weiss J
Mol Pharmacol; 2004 Nov; 66(5):1332-9. PubMed ID: 15308763
[TBL] [Abstract][Full Text] [Related]
33. The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.
Holland ML; Panetta JA; Hoskins JM; Bebawy M; Roufogalis BD; Allen JD; Arnold JC
Biochem Pharmacol; 2006 Apr; 71(8):1146-54. PubMed ID: 16458258
[TBL] [Abstract][Full Text] [Related]
34. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
Tang XQ; Bi H; Feng JQ; Cao JG
Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636
[TBL] [Abstract][Full Text] [Related]
35. Liposomal sphingomyelin influences the cellular lipid profile of human lymphoblastic leukemia cells without effect on P-glycoprotein activity.
Zembruski NC; Nguyen CD; Theile D; Ali RM; Herzog M; Hofhaus G; Heintz U; Burhenne J; Haefeli WE; Weiss J
Mol Pharm; 2013 Mar; 10(3):1020-34. PubMed ID: 23379426
[TBL] [Abstract][Full Text] [Related]
36. Activators of P-glycoprotein: Structure-activity relationships and investigation of their mode of action.
Sterz K; Möllmann L; Jacobs A; Baumert D; Wiese M
ChemMedChem; 2009 Nov; 4(11):1897-911. PubMed ID: 19777523
[TBL] [Abstract][Full Text] [Related]
37. P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential.
Alemán C; Annereau JP; Liang XJ; Cardarelli CO; Taylor B; Yin JJ; Aszalos A; Gottesman MM
Cancer Res; 2003 Jun; 63(12):3084-91. PubMed ID: 12810633
[TBL] [Abstract][Full Text] [Related]
38. Cholesterol modulates P-glycoprotein activity in human peripheral blood mononuclear cells.
Troost J; Albermann N; Emil Haefeli W; Weiss J
Biochem Biophys Res Commun; 2004 Apr; 316(3):705-11. PubMed ID: 15033457
[TBL] [Abstract][Full Text] [Related]
39. Imatinib resistance in multidrug-resistant K562 human leukemic cells.
Assef Y; Rubio F; Coló G; del Mónaco S; Costas MA; Kotsias BA
Leuk Res; 2009 May; 33(5):710-6. PubMed ID: 18977528
[TBL] [Abstract][Full Text] [Related]
40. Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells.
Mutoh K; Tsukahara S; Mitsuhashi J; Katayama K; Sugimoto Y
Cancer Sci; 2006 Nov; 97(11):1198-204. PubMed ID: 16925584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
